• WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors

    WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors

    The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.

    Read More

Patient Care

  • WVU Cancer Institute debuts treatment for liver metastases

    WVU Cancer Institute debuts treatment for liver metastases

    A team of surgical oncologists from the WVU Cancer Institute, including Wallis Marsh, MD, Carl Schmidt, MD, and Brian Boone, MD, have performed the state’s first isolated hepatic perfusion, an operation that delivers chemotherapy directly to the liver to treat metastases that cannot be surgically removed.

    Read More

  • 2019 Van Liere Research Conference

    2019 Van Liere Research Conference

    The 54th Annual Van Liere Research Conference (formerly the E.J. Van Liere Convocation and HSC Research Day) will be held on March 21st and 22nd, 2019 on the WVU Health Sciences Campus in Morgantown, WV.

    Read More